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Abstract Mastoparan B (MP-B), an amphiphilic K-helical
peptide isolated from hornet venom, and its Ala-substituted
analogs were examined for their effectiveness on phospholipase D
(PLD) activity in L1210 cells. PLD activity was determined by
measuring phosphatidylethanol produced from [3H]myristate-
labelled cells in the presence of ethanol. PLD activity was
stimulated by MP-B, 4MP-B (Lys4CAla), and 12MP-B
(Lys12CAla), but not by 3MP-B (Leu3CAla) and 9MP-B
(Trp9CAla). Other MPs including mastoparan 7 also stimu-
lated the PLD activity, but inactive mastoparan 17 did not. The
stimulatory effect of various MP analogs could be correlated
with their K-helical contents. The PLD activity stimulated by
MP-B was not affected by G-protein blocking chemicals. The
extent of PLD stimulation by various MP-Bs, as well as by
digitonin and L-escin, correlated with the permeability of the
membrane to ethidium bromide. These results suggest that the
stimulation of PLD activity by MP-B in L1210 cells is probably
coupled with membrane perturbation brought about by the
peptide.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Mastoparan B (MP-B), a cationic tetradecapeptide isolated
from the venom of hornet Vespa basalis [1], is a homolog of
mastoparans (MPs) found in various wasps. MPs exhibit a
wide variety of biological e¡ects such as stimulation of hista-
mine release from mast cells, erythrocyte lysis, and antimicro-
bial activity against bacteria [1^6]. They also a¡ect the activity
of phospholipase A2 [7], C [8], and D [9] and induce the
mitochondria permeability transition [10] and cytosolic Ca2
elevation [11]. All these e¡ects have been related to the acti-
vation of G-proteins [12^14] and/or induction of membrane
pore formation [11,15]. However, the mechanism of MP ac-
tion remains elusive as more diverse cellular functions are
observed.
Various natural and synthetic MP analogs have been devel-
oped to study the structure-activity relationship. For example,
mastoparan 7 (Mas-7) and mastoparan 17 (Mas-17) are used
as an active MP and an inactive MP, respectively [10^14].
Mas-7 has been obtained by substituting Ala for the positive
Lys in position 12 and Mas-17 by substituting Lys for the
neutral Leu in position 6 [12]. Similarly, Park et al. synthe-
sized a series of Ala-substituted MP-B analogs and studied
their interactions with phospholipid bilayers [16,17]. MP-B
adopts an amphiphilic K-helical structure, hydrophobic resi-
dues providing a nonpolar environment on one side and hy-
drophilic residues a polar environment on the other side [18].
When residues with hydrophobic side groups (Leu-1, Leu-3,
Ile-6, Val-7, Trp-9, Val-13, Leu-14) in the MP-B analogs were
substituted with Ala, the hemolytic and antimicrobial activ-
ities decreased signi¢cantly along with the decreased K-helical
contents [16]. On the other hand, when Ala was substituted
for hydrophilic residues (Lys-2, Lys-4, Ser-5, Ser-8, Lys-11,
Lys-12), the K-helical contents and the biological e¡ects in-
creased substantially [17]. The opposite properties of these
series of MP-B analogs suggest that these series could be
used to investigate the structure-activity relationship of MP
toxins on a broad spectrum of biological processes.
Recently there were several reports on the e¡ects of MP on
phospholipase D (PLD) activities in some cell lines. One
claimed inhibitory e¡ect in HL60 cells [19], while others re-
ported stimulatory e¡ects in human astrocytoma cells [9] and
in green alga Chlamydomonas eugametos [20]. PLD catalyzes
hydrolysis of phosphatidylcholine to produce phosphatidic
acid, a lipid mediator, and the action of PLD is regulated
by a variety of hormones, growth factors, and other extra-
cellular signals [21]. Thus the PLD associated with membrane
has emerged as one of the major signal-activated phospholip-
ases [22]. In an e¡ort to understand the action of MP, we
investigated the e¡ects of MP-B analogs on PLD activity in
lymphocytic mouse leukemia L1210 cells. The PLD in L1210
cells has shown to be unique in that it is activated by oleate
[23]. In this article, we present results which show that the
extent of stimulation of the PLD in L1210 cells by MP-B
analogs can be correlated with their capability of membrane
perturbation.
2. Materials and methods
2.1. Materials
[9,10-3H(N)]myristic acid and [5,6,8,9,11,12,14,15-3H(N)]arachidon-
ic acid were purchased from Dupont NEN. Synthesized Mas-7 and
Mas-17 were obtained from Peninsula Laboratories (Belmont, CA).
Mastoparans (Vepula lewisii, M-5280; Polistes jadwagae, M-3545),
mast cell degranulating peptide HR1, amyloid L-protein (25^35), per-
tussis toxin, benzalkonium chloride, and L-escin were from Sigma.
Daunomycin was obtained from Calbiochem and digitonin was
from Merck. RPMI 1640 medium and fetal bovine serum were from
GibcoBRL. MP-B and its analogs were synthesized and puri¢ed as
the method described by Park et al. [16,17]. Purities of synthesized
MP-Bs were further characterized by a JASCO HPLC amino acid
analysis system and molecular weights were determined by fast
atom bombardment mass spectra using a JEOL SX-102A. Indolicidin
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was supplied by Dr. J.S. Park (Seoul National University). PEt was
prepared from phosphatidylcholine using cabbage PLD according to
the published procedure [24].
2.2. Cell culture and prelabelling
L1210 cells were grown in HEPES-bu¡ered RPMI 1640 medium
supplemented with 10% (v/v) heat-inactivated fetal bovine serum and
subcultured every 2^3 days so that the cells density did not exceed 1^
2U106/ml. Cells were labelled with [3H]myristic acid (1.5 WCi/ml, for
the measurement of PLD activity) or [3H]arachidonic acid (0.8 WCi/
ml, for the measurement of PLA2 activity) for 3 h according to the
method described by Lee et al. [23].
2.3. Assay of PLD and PLA2 activities
PLD activity in intact L1210 cells was assayed as described previ-
ously [23]. Harvested 3H-labelled cells were washed twice with phos-
phate-bu¡ered saline and were resuspended in an assay medium con-
taining 20 mM HEPES (pH 7.2), 137 mM NaCl, 2.7 mM KCl, 3 mM
MgCl2, 2 mM CaCl2, 2 mM EGTA, and 1 mg/ml BSA. The ¢nal
assay mixtures (200 Wl) containing 1.5% ethanol with various agents
as indicated were incubated for 20 min at 37‡C. The reaction was
terminated by addition of 2 ml of chloroform/methanol/1 N HCl
(100:50:3) and [3H]PEt was separated on a TLC plate using ethyl-
acetate/iso-octane/acetic acid/water (13:2:3:10) solvent system. PLA2
activity in intact L1210 cells was assayed as above except that, for
separation of [3H]arachidonic acid, authentic arachidonic acid was
added and heptane/diethylether/acetic acid (60:40:2) solvent system
was used. The presented data were normalized to a total radioactivity
of 2U105 cpm. The counting e⁄ciency of measured radioactivity was
52%. Assays were carried out in duplicate and each set of experiments
was repeated 3 to 4 times.
2.4. Measurement of membrane permeability
Membrane permeability was measured with £uorescent dye ethidi-
um bromide (EtBr) as described previously [11]. An aliquot of cells
(5U105/ml) was resuspended in 1.2 ml of the assay medium contain-
ing 25 WM EtBr. After addition of indicated chemicals, the cell sus-
pensions were incubated for 10 min at 37‡C and the EtBr in£ux was
determined by measuring changes in £uorescence intensity. The exci-
tation wavelength was 360 nm and the emission wavelength was 580
nm.
3. Results
3.1. Di¡erential stimulation of PLD by MP-B analogs
Fig. 1A shows that di¡erent MP-B analogs (Table 1) exhibit
di¡erent stimulatory e¡ects on the PLD activity in intact
L1210 cells. MP-B, 4MP-B, and 12MP-B stimulated the
PLD activity, whereas 3MP-B and 9MP-B showed no stimu-
lation. 12MP-B was most e¡ective and enhanced the PLD
activity 6-fold at 25 WM concentration. MP-B and 4MP-B
increased the PLD activity approximately 4-fold at the 25 to
50 WM concentration range. This all or none stimulatory be-
havior of MP-B analogs was further observed with other MP
homologs (Fig. 1B). Mas-7, MP (V. lewisii), and MP (P. jad-
wagae) increased the PLD activity, but Mas-17 did not show
any stimulatory e¡ect. Mas-7 seemed to be more potent than
12MP-B, and a maximum enhancement of 15-fold was ob-
served. The natural MPs, MP (V. lewisii) and MP (P. jadwa-
gae), obtained from corresponding wasp venoms, exerted sim-
ilar e¡ects at 25 WM concentration, but at 50 WM the e¡ect of
MP (V. lewisii) surpassed that of MP (P. jadwagae).
Other related amphiphilic peptides such as mast cell degran-
ulating peptide HR1 [25], amyloid L-protein (25^35) [26], in-
dolicidin [27], and apidaecin Ib [28] were also examined for
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Fig. 1. E¡ects of various MPs on the PLD activity in L1210 cells.
[3H]myristate-labelled L1210 cells were incubated for 20 min with
(A) MP-B and its analogs; (B) MPs and its analogs, Mas-7 and
Mas-17 as indicated. The radioactivity of [3H]PEt produced was
normalized to a total labelled radioactivity of 2U105 cpm. Mean of
3^4 determinations and bars indicate the standard deviation.
Table 1
Amino acid sequence of MP-B and its analogs
Peptide Position
1 2 3 4 5 6 7 8 9 10 11 12 13 14
MP-B (V. basalis) Leu Lys Leu Lys Ser Ile Val Ser Trp Ala Lys Lys Val Leu NH2
3MP-B Leu Lys Ala Lys Ser Ile Val Ser Trp Ala Lys Lys Val Leu NH2
4MP-B Leu Lys Leu Ala Ser Ile Val Ser Trp Ala Lys Lys Val Leu NH2
9MP-B Leu Lys Leu Lys Ser Ile Val Ser Ala Ala Lys Lys Val Leu NH2
12MP-B Leu Lys Leu Lys Ser Ile Val Ser Trp Ala Lys Ala Val Leu NH2
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their e¡ectiveness on the PLD in L1210 cells. A signi¢cant
activation similar to that of MP (P. jadwagae) was observed
with the mast cell degranulating peptide, but with amyloid L-
protein (25^35) and indolicidin only moderate stimulatory ef-
fects were detected (data not shown). The apidaecin Ib had no
e¡ect on the PLD activity (data not shown).
3.2. Insensitivity of the MP-B stimulated PLD to G-protein
related chemicals
To investigate whether the observed stimulation of PLD by
MP-B is related with the G-protein, the e¡ect of some agents,
such as pertussis toxin known to be a G-protein inhibitor
[13,22], on the MP-B stimulated PLD activity was studied.
As shown in Fig. 2A, the stimulated PLD activities were
not inhibited by the presence of pertussis toxin at 2.5 Wg/ml.
When benzalkonium chloride, another competitive antagonist
for the Mas-7 stimulated GTPase activity of Gi [12], was
added to the assay medium of PLD, the PLD activity was
enhanced, instead of being inhibited (Fig. 2B). The benzalko-
nium ion, a hydrophobic quaternary amine, is also known to
be an antibacterial chemical [29], and its stimulatory e¡ect
seems consistent with that of the hydrophobic MP-Bs. Dau-
nomycin, with a known lipid bilayer stabilizing property, has
been suggested as a disruptor of cellular signaling pathways
by impairing proper G-protein couplings [30]. Like other
G-protein related chemicals tested, daunomycin exerted no
e¡ect on the MP-B stimulated PLD up to 200 WM concen-
tration (Fig. 2C). These observations indicate that the stimu-
latory e¡ect of MP-B has no connection with the G-protein
linked pathways.
3.3. Induction of membrane permeability by MP-B analogs
Numerous actions of MP, including pore formation, have
been related to the membrane perturbation induced by inter-
action of MP with lipid bilayer [10,11,15]. Hence, we com-
pared the PLD stimulating e¡ect of MP-Bs with that of other
membrane-perturbing chemicals, digitonin and L-escin (Fig.
3A). The enhancement of PLD activity, nearly 7-fold by dig-
itonin and 4-fold by L-escin, was similar to that by MP-B and
12MP-B. Intrigued by the fact that PLD activity is enhanced
by membrane-perturbing agents, we investigated the quantita-
tive relationship between the PLD activity and the extent of
pore formation measured by the in£ux of EtBr into L1210
cells (Fig. 3B). As expected, the active MP-B and 12MP-B
allowed the EtBr in£ux, but inactive 3MP-B did not. The
increase in permeability by active forms of MP-B is in good
agreement with the reported increase by Mas-7 [11]. The ob-
served correlation between the £uorescence changes, due to
pore formation and the EtBr in£ux, and the enhancement of
the PLD activity seems quite remarkable. This correlation
suggests that the membrane-perturbing action of the MP-Bs
might lead to the stimulation of the PLD activity.
3.4. E¡ect of MP-Bs on arachidonate release
Generally MP has been reported as stimulators for some
phospholipases in various cell types [7^9]. We extended inves-
tigation of the MP-B e¡ect to the PLA2 activity in L1210 cells
(Fig. 4). The release of arachidonic acid was stimulated by
MP-B, 4MP-B and 12MP-B, all of which stimulate the PLD
activity, but not by the inactive analog 3MP-B.
4. Discussion
Earlier results showed that the K-helical content of MP-B
and its Ala-substituted analogs is a key structural parameter
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Fig. 2. E¡ects of chemicals related to G-protein linked pathways on the MP stimulated PLD activity in L1210 cells. [3H]myristate-labelled
L1210 cells were incubated for 20 min with MP-Bs (25 WM) or Mas-7 (12.5 WM), in the absence and presence of 2.5 Wg/ml pertussis toxin pre-
incubated for 10 min (A); in the absence and presence of 10 Wg/ml benzalkonium chloride (B); in the absence and presence of 50 WM (hatched)
and 200 WM (closed) of daunomycin (C). Mean of 3^4 determinations.
Table 2
K-Helical content of MP-B and its Ala-substituted analogs
Peptide % K Helix
Neutral liposomesa Acidic liposomesb
MP-B 43 57
3MP-B 0 34
4MP-B 48 61
9MP-B 0 27
12MP-B 50 78
The K-helical contents were calculated from CD spectra obtained
previously in TES bu¡er (pH 7.4) [16,17].
aEgg-yolk phosphatidylcholine liposomes.
bEgg-yolk phosphatidylcholine:phosphatidylglycerol (3:1) liposomes.
The ratio of peptide to lipid concentration was 0.1 mM to 1 mM.
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in the structure-activity relationship in antimicrobial and he-
molytic activities [16,17]. Similarly the K-helical content of the
MP-B analogs, summarized in Table 2, appears to correlate
with the increased PLD activity in L1210 cells (Fig. 1A). The
MP-B analogs with high K-helical content, such as MP-B,
4MP-B, and 12MP-B exerted stimulatory e¡ects on the PLD
in L1210 cells. On the other hand, the analogs with low K-
helical structure, 3MP-B and 9MP-B, were totally ine¡ective.
This relationship was further reinforced by other natural MPs
and MP analogs, Mas-7 and Mas-17 (Fig. 1B). As expected,
the natural MPs and analog Mas-7 showed stimulatory ef-
fects, whereas Mas-17, known to have a low K-helical content
[12], had no e¡ect at all. These results suggest that the high K-
helical content of MPs and their analogs might be a critical
determinant for the stimulatory e¡ect of the MP on the PLD
activity in L1210 cells.
Generally the action of MP has been interpreted in two
aspects : one as a modulator of the G-protein function and
the other as a membrane-perturbing amphiphilic peptide.
Since none of the G-protein blocking chemicals, including
pertussis toxin, in£uenced the e¡ect of MP-B on the PLD
activity under the experimental conditions (Fig. 2), the in-
volvement of the G-protein pathway in the MP-B modulated
PLD activity in L1210 cells could be ruled out. An earlier
¢nding that the PLD activity in this cell is not dependent
on guanosine 5P-(3-O-thio)triphosphate (GTPQS) [23] is con-
sistent with the insensitivity of the MP-B action to the G-
protein blockers. A similar insensitivity of the PLD stimula-
tion by MP to pertussis toxin was reported in human astro-
cytoma cells, in which the PLD was not mediated by G-pro-
teins [9]. In contrast with these cell lines, the GTPQS
stimulated PLD activity in HL60 cells was inhibited by MP
[19]. The PLD in HL60 cells has been shown to be dependent
on ADP-ribosylation factor (ARF), a small G-protein [19,23].
The induction of permeability in L1210 cells by MP-B ana-
logs (Fig. 3B) indicates that the active MP-Bs may act as a
membrane-perturbing amphiphilic peptide. With respect to
the membrane perturbation by MP, much information have
been accumulated such as transition in mitochondrial perme-
ability [10], elevation of cytosolic Ca2 through membrane
pores [11], and permeability enhancement in various biomem-
branes [15^17]. It has also been pointed out that the mem-
brane-perturbing action of MPs including dye leakage from
lipid vesicles can correlate with their K-helical contents [15^
18]. Recently a series of synthetic amphiphilic peptides, which
forms K-helical structure in the presence of vesicles, was
shown to exhibit a strong membrane-perturbing activity [31].
The permeabilizing action of MP-B analogs with high K-hel-
ical contents is most likely through altering lipid bilayer struc-
ture of the L1210 cell membrane. This permeabilizing action
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Fig. 3. E¡ects of membrane-perturbing chemicals on PLD activity
in L1210 cells. A: Comparison of e¡ects of MP-Bs and membrane-
permeabilizing chemicals on the PLD activity. [3H]myristate-labelled
L1210 cells were incubated for 20 min in the presence of MP-Bs (25
WM each), digitonin (30 Wg/ml), or L-escin (30 Wg/ml). B: E¡ects of
MP-B and its analogs on EtBr permeability in L1210 cells. The
EtBr (25 WM) in£ux was carried out in the presence of 25 WM of
MP-Bs. After 10 min incubation the relative £uorescence was deter-
mined at wavelengths of 360 nm excitation, 580 nm emission. As a
permeability control the permeabilizing chemicals, digitonin and
L-escin (30 Wg/ml each), were included. Mean of 3^4 determinations.
Fig. 4. E¡ects of MP-B and its analogs on PLA2 activity in L1210
cells. [3H]arachidonic acid-labelled L1210 cells were incubated for
20 min with MP-B and its analogs at the concentration of 25 WM
each. The radioactivity of [3H]arachidonic acid released was normal-
ized to a total labelled radioactivity of 2U105 cpm. Mean of 3^4
determinations.
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of MP-Bs might in turn stimulate the PLD presented in the
L1210 cell membranes. The PLD stimulatory e¡ects observed
with digitonin and L-escin, permeabilizing agents used fre-
quently, appear to coincide with those of active MP-Bs (Fig.
3A). The similarity in the stimulation behavior between MP-
Bs and permeabilizing agents implies that the membrane per-
turbation is an important factor for stimulating the PLD in
L1210 cells. Since the PLD in L1210 is activated by oleate, we
speculate that the oleate might act as a detergent to activate
the PLD through membrane perturbation and/or permeabili-
zation [23,32].
The membrane-perturbing action of MP-Bs in L1210 cells
was related not only with stimulating the PLD activity but
also with inducing arachidonic acid release (Fig. 4). The re-
lease of arachidonic acid upon exposure to MP-B followed a
similar structure-activity relationship except that the extent of
stimulation was somewhat less than that of PLD. This result
suggests a possibility of multiple e¡ects of MP-B on various
phospholipases present in the membrane of L1210 cells. In
fact, broader multiple e¡ects of MP beside on phospholipase
were observed in human neutrophils [33]. In summary, the
stimulation of PLD activity in L1210 cells by MP-B and
MP-B analogs with high K-helical contents may be coupled
with membrane perturbation. Additionally this study demon-
strates that the series of Ala-substituted MP-B analogs pro-
vides a valuable tool for investigating the structure-activity
relationship of MP homologs.
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